Sanai

Transforming Drug Development through Intelligent Automation


Sanai Inc. is global leader in advanced artificial intelligence specifically focused on the pharmaceutical and biotechnology industries. 

We are transforming the way pharmaceutical companies do business by harnessing the power of artificial intelligence to accelerate drug development, reduce development costs, and deliver maximal returns on your R&D investments.

With our team of experienced drug developers and skilled AI engineers, we are your partner of choice in shaping the AI-future of your life sciences organization. Your products transform human lives for the better – let our pharma-focused AI platform transform yours!


Founders

John Walters
CEO

Serial entrepreneur, and life sciences  leader with experience scaling organizations from pre-clinical to commercial.

Magic Madrigal
CTO

Head of Enterprise Engineering and AI architect, with experience in AI and SaaS. Leadership role in leading Reddit through IPO, with a focus on compliance.

Dr. Prasad Dande
CSO

Seasoned Pharma-executive specializing in corporate strategy and product development. 25+ years in Leadership roles, with Roche/Genentech, Gilead Sciences, Baxter Healthcare, Abbott Laboratories.

Advisory Board

Paul Alloway

Paul is an experienced bio-pharma executive and has previously served as President and COO at Homology Medicines, VP and head of legal at Foghorn Therapeutics & VP and senior counsel at DRI Capital

Chris Holscher

Chris is a pharma-industry veteran and currently serves as VP of Quality Assurance at Ceribell Inc. He is a seasoned veteran of the product development cycle and is also a certified quality auditor.

Bobby Ivotchev

Bobby is currently serving as CFO at FireDex. He is a Finance, and FinTech guru,  managed Billions at AMAT and Millions at Unity, LRCX, and FireDex.

Dr. Ethan garner

Dr. Garner is a Professor of Molecular and Cellular Biology at Harvard University. Dr. Garner has published extensively in high impact journals such as Science, Nature Communications, and Nature Microbiology

Dr. Mwe Mwe Chao

Dr. Mwe Mwe Chao is a pediatric oncologist with an extensive clinical research background having held leadership roles at Gilead Sciences, Rigel Pharmaceuticals, and Ideaya Biosciences. She has also served as  Physician in Pediatric Hematology-Oncology, Hannover Medical School, Hannover, Germany.

Zachary Reiss-Davis

Zachary is Sanai’s resident Marketing Guru. Zachary has held marketing leadership roles at Dusty Robotics, Procore Technologies, Fieldwire, and Salesforce